Genomic profiling in renal cell carcinoma
Crossref DOI link: https://doi.org/10.1038/s41581-020-0301-x
Published Online: 2020-06-19
Published Print: 2020-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dizman, Nazli http://orcid.org/0000-0002-3907-8513
Philip, Errol J.
Pal, Sumanta K.
Text and Data Mining valid from 2020-06-19
Version of Record valid from 2020-06-19
Article History
Accepted: 28 April 2020
First Online: 19 June 2020
Competing interests
: S.K.P. consults for Genentech, Aveo, Eisai, Roche, Pfizer, Novartis, Exelixis, Ipsen, BMS and Astellas. N.D. and E.J.P. declare no competing interests.